GEODE CAPITAL MANAGEMENT, LLC - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 49 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q4 2020$402,000
+2.6%
400,0000.0%0.00%
Q3 2020$392,000
+0.3%
400,0000.0%0.00%
Q2 2020$391,000
+5.1%
400,0000.0%0.00%
Q1 2020$372,000
-95.1%
400,000
-95.0%
0.00%
-100.0%
Q4 2019$7,584,000
+235.1%
8,000,000
+220.0%
0.00%0.0%
Q3 2019$2,263,000
-1.4%
2,500,000
-0.4%
0.00%0.0%
Q2 2019$2,295,000
-81.8%
2,510,000
-82.1%
0.00%
-50.0%
Q4 2018$12,634,000
+93.0%
14,000,000
+100.0%
0.00%0.0%
Q3 2018$6,546,000
-52.9%
7,000,000
-53.3%
0.00%
-50.0%
Q2 2018$13,903,000
+58.6%
15,000,000
+50.0%
0.00%
+33.3%
Q1 2018$8,764,000
-0.1%
10,000,0000.0%0.00%0.0%
Q4 2017$8,775,000
+62.3%
10,000,000
+66.7%
0.00%
+50.0%
Q3 2017$5,407,000
-29.4%
6,000,000
-6.6%
0.00%
-50.0%
Q3 2016$7,663,000
-40.7%
6,423,000
-37.7%
0.00%
-42.9%
Q2 2016$12,928,000
+32.5%
10,317,000
+37.6%
0.01%
+40.0%
Q1 2016$9,759,0007,500,0000.01%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q2 2020
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 70,783,000$69,363,0006.27%
INCOME RESEARCH & MANAGEMENT 14,978,000$14,536,0005.17%
PIPER SANDLER & CO. 5,000,000$4,852,0003.63%
Western Asset Management Company, LLC 42,946,000$42,102,0003.46%
PenderFund Capital Management Ltd. 4,000,000$5,225,0001.45%
Bracebridge Capital, LLC 5,500,000$5,335,0000.85%
WESTWOOD HOLDINGS GROUP INC 43,185,000$42,490,0000.54%
CORBYN INVESTMENT MANAGEMENT INC/MD 1,025,000$995,0000.52%
LMR Partners LLP 22,235,000$21,742,0000.45%
JUPITER ASSET MANAGEMENT LTD 35,000,000$34,357,0000.36%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders